There were 1,836 press releases posted in the last 24 hours and 442,592 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Paras Biopharmaceuticals is Highly Recommended for Biologics CDMO – Development, Scale-up & Production

TO:
Mark Jackson
Paras Biopharmaceuticals Finland Oy
58442905993

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image